Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.

Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, Appel MC.

Clin Immunol. 2004 Sep;112(3):273-83.

PMID:
15308121
2.

[Application of NOD/SCID mice in research of experimental hematology - review].

Yu WJ, Yang WH, Shi ZX, Yang XD, Wang HJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):964-8. Review. Chinese.

PMID:
18718101
3.

Hepatocyte growth factor gene therapy for islet transplantation.

Rao P, Cozar-Castellano I, Roccisana J, Vasavada RC, Garcia-Ocaña A.

Expert Opin Biol Ther. 2004 Apr;4(4):507-18. Review.

PMID:
15102600
4.

Islet transplantation: immunological perspectives.

Inverardi L, Kenyon NS, Ricordi C.

Curr Opin Immunol. 2003 Oct;15(5):507-11. Review.

PMID:
14499257
5.

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.

Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Gambrell B, Bottino R, Styche AJ, Trucco M.

Stem Cells. 2003;21(4):377-88. Review.

6.

Pancreatic transplantation as a means of insulin delivery.

Lacy PE.

Diabetes Care. 1982 May-Jun;5 Suppl 1:93-7. Review.

PMID:
6821308
7.

Transplantation without immunosuppression.

Faustman D, Lacy PE, Davie JM.

Diabetes. 1982 Aug;31 Suppl 4:11-6. Review.

PMID:
6819960
8.

[Treatment of diabetes mellitus with transplantation of immunoprotected pancreatic islet tissue].

Kulseng B, Espevik T, Skjåk-Braek G.

Tidsskr Nor Laegeforen. 1999 Nov 20;119(28):4219-23. Review. Norwegian.

PMID:
10668387
9.

Experimental transplantation of pancreatic islet allografts.

Schulak JA, Reckard CR.

J Surg Res. 1978 Dec;25(6):562-71. Review. No abstract available.

PMID:
102875
10.

Autoimmunity versus allo- and xeno-reactivity in SCID mice.

Elkon KB, Ashany D.

Int Rev Immunol. 1994;11(4):283-93. Review.

PMID:
7806942
11.

The contribution of MHC antigen modulation to islet allograft rejection.

Markmann JF, Schachner MS, Bassiri H, Barker CF, Naji A.

Horm Metab Res Suppl. 1990;25:104-8. Review. No abstract available.

PMID:
2088947
12.
13.

Pancreatic islet xenotransplantation: barriers and prospects.

Rayat GR, Gill RG.

Curr Diab Rep. 2003 Aug;3(4):336-43. Review.

PMID:
12866998
14.

Update on pancreatic islet cell transplantation.

Jung PJ, Merrell RC.

Semin Surg Oncol. 1990;6(2):122-5. Review.

PMID:
2107570
15.

Chemokines in islet allograft rejection.

Abdi R, Means TK, Luster AD.

Diabetes Metab Res Rev. 2003 May-Jun;19(3):186-90. Review.

PMID:
12789651
16.

Manipulation of pancreatic islet cells in allotransplantation.

Tze WJ, Tai J.

Transplant Proc. 1982 Dec;14(4):714-23. Review. No abstract available.

PMID:
6820204
17.

Xenogeneic islet transplantation.

Simeonovic CJ.

Xenotransplantation. 1999 Feb;6(1):1-5. Review. No abstract available.

PMID:
10355727
18.

The use of SCID mice in biotechnology and as a model for human disease.

Sandhu JS, Boynton E, Gorczynski R, Hozumi N.

Crit Rev Biotechnol. 1996;16(1):95-118. Review.

PMID:
8935910
19.

Immunologic problems in islet transplantation.

Barker CF, Naji A, Silvers WK.

Diabetes. 1980;29 Suppl 1:86-92. Review. No abstract available.

PMID:
6766416
20.

Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse.

Pober JS, Bothwell AL, Lorber MI, McNiff JM, Schechner JS, Tellides G.

Springer Semin Immunopathol. 2003 Sep;25(2):167-80. Review.

PMID:
12955465
Items per page

Supplemental Content

Write to the Help Desk